Your browser doesn't support javascript.
loading
Radiotherapy-Induced Astrocyte Senescence Promotes an Immunosuppressive Microenvironment in Glioblastoma to Facilitate Tumor Regrowth.
Ji, Jianxiong; Ding, Kaikai; Cheng, Bo; Zhang, Xin; Luo, Tao; Huang, Bin; Yu, Hao; Chen, Yike; Xu, Xiaohui; Lin, Haopu; Zhou, Jiayin; Wang, Tingtin; Jin, Mengmeng; Liu, Aixia; Yan, Danfang; Liu, Fuyi; Wang, Chun; Chen, Jingsen; Yan, Feng; Wang, Lin; Zhang, Jianmin; Yan, Senxiang; Wang, Jian; Li, Xingang; Chen, Gao.
Afiliação
  • Ji J; Department of Neurosurgery, the Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, Zhejiang, 310000, P. R. China.
  • Ding K; Department of Neurosurgery, Qilu Hospital of Shandong University and Brain Science Research Institute, Cheeloo College of Medicine, Shandong University, 107 Wenhua Xi Road, Jinan, Shandong, 250012, P. R. China.
  • Cheng B; Key Laboratory of Brain Functional Remodeling, Shandong University, 107 Wenhua Xi Road, Jinan, Shandong, 250012, P. R. China.
  • Zhang X; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Luo T; Department of Neurosurgery, Qilu Hospital of Shandong University and Brain Science Research Institute, Cheeloo College of Medicine, Shandong University, 107 Wenhua Xi Road, Jinan, Shandong, 250012, P. R. China.
  • Huang B; Key Laboratory of Brain Functional Remodeling, Shandong University, 107 Wenhua Xi Road, Jinan, Shandong, 250012, P. R. China.
  • Yu H; Department of Radiation Oncology, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310000, P. R. China.
  • Chen Y; Department of Radiation Oncology, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, P. R. China.
  • Xu X; Department of Neurosurgery, Qilu Hospital of Shandong University and Brain Science Research Institute, Cheeloo College of Medicine, Shandong University, 107 Wenhua Xi Road, Jinan, Shandong, 250012, P. R. China.
  • Lin H; Key Laboratory of Brain Functional Remodeling, Shandong University, 107 Wenhua Xi Road, Jinan, Shandong, 250012, P. R. China.
  • Zhou J; Department of Neurosurgery, Qilu Hospital of Shandong University and Brain Science Research Institute, Cheeloo College of Medicine, Shandong University, 107 Wenhua Xi Road, Jinan, Shandong, 250012, P. R. China.
  • Wang T; Key Laboratory of Brain Functional Remodeling, Shandong University, 107 Wenhua Xi Road, Jinan, Shandong, 250012, P. R. China.
  • Jin M; Department of Neurosurgery, Qilu Hospital of Shandong University and Brain Science Research Institute, Cheeloo College of Medicine, Shandong University, 107 Wenhua Xi Road, Jinan, Shandong, 250012, P. R. China.
  • Liu A; Key Laboratory of Brain Functional Remodeling, Shandong University, 107 Wenhua Xi Road, Jinan, Shandong, 250012, P. R. China.
  • Yan D; Department of Radiation Oncology, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310000, P. R. China.
  • Liu F; Department of Neurosurgery, the Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, Zhejiang, 310000, P. R. China.
  • Wang C; Department of Neurosurgery, the Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, Zhejiang, 310000, P. R. China.
  • Chen J; Department of Neurosurgery, the Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, Zhejiang, 310000, P. R. China.
  • Yan F; Department of Neurosurgery, the Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, Zhejiang, 310000, P. R. China.
  • Wang L; Department of Neurosurgery, the Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, Zhejiang, 310000, P. R. China.
  • Zhang J; Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310000, P. R. China.
  • Yan S; Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310000, P. R. China.
  • Wang J; Department of Radiation Oncology, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310000, P. R. China.
  • Li X; Department of Neurosurgery, the Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, Zhejiang, 310000, P. R. China.
  • Chen G; Department of Neurosurgery, the Second Affiliated Hospital of Zhejiang University School of Medicine, Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, Zhejiang, 310000, P. R. China.
Adv Sci (Weinh) ; 11(15): e2304609, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38342629
ABSTRACT
Accumulating evidence suggests that changes in the tumor microenvironment caused by radiotherapy are closely related to the recurrence of glioma. However, the mechanisms by which such radiation-induced changes are involved in tumor regrowth have not yet been fully investigated. In the present study, how cranial irradiation-induced senescence in non-neoplastic brain cells contributes to glioma progression is explored. It is observed that senescent brain cells facilitated tumor regrowth by enhancing the peripheral recruitment of myeloid inflammatory cells in glioblastoma. Further, it is identified that astrocytes are one of the most susceptible senescent populations and that they promoted chemokine secretion in glioma cells via the senescence-associated secretory phenotype. By using senolytic agents after radiotherapy to eliminate these senescent cells substantially prolonged survival time in preclinical models. The findings suggest the tumor-promoting role of senescent astrocytes in the irradiated glioma microenvironment and emphasize the translational relevance of senolytic agents for enhancing the efficacy of radiotherapy in gliomas.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Glioma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Glioma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article